Lung clearance index (LCI2.5 ) changes after initiation of Elexacaftor/Tezacaftor/Ivacaftor in children with cystic fibrosis aged between 6 and 11 years: The "real‐world" differs from trial data.
- Resource Type
- Article
- Source
- Pediatric Pulmonology; May2024, Vol. 59 Issue 5, p1449-1453, 5p
- Subject
- Language
- ISSN
- 87556863